(Date:7/3/2008)... TexasA dynamic way to alter the shape and size of...t of proteins has been developed by biological che...ryan Kaehr at The University of Texas at Austin. ,...d three-dimensional microstructures, known as hydr...d the hydrogels by altering the chemistry of the e...
(Date:7/3/2008)... Moines, Iowa July 3, 2008 Endangered wild orang...harply in Sumatra and Borneo than previously estim...th by Great Ape Trust of Iowa scientist Dr. Serge ...Oryx The International Journal of Conservation . ...f orangutans, found only on the islands of Sumatra...
(Date:7/2/2008)...on, Virginia (July 2, 2008) Led by a bold commitm...l powers have the opportunity at the upcoming G8 S...ction against climate change. , German Chancello...os over four years to conserve tropical forests, f...tection, starts to address a major source of green...
(Date:7/2/2008)...the specter of a worldwide outbreak of avian or "b...new drugs are desperately needed since some strain...o the current roster of anti-flu remedies. , Now...p of resources at the San Diego Supercomputer Cent...re than two dozen promising and novel compounds fr...
Breaking Biology News(10 mins):'Smart' materials get smarter with ability to better control shape and size 2'Smart' materials get smarter with ability to better control shape and size 3Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 2Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 3Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 4Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 5G8 summit: Opportunity for immediate action on climate change 2G8 summit: Opportunity for immediate action on climate change 3UC San Diego researchers identify potential new drug candidates to combat 'bird flu' 2UC San Diego researchers identify potential new drug candidates to combat 'bird flu' 3UC San Diego researchers identify potential new drug candidates to combat 'bird flu' 4Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon 28R 29 for Chronic Hepatitis C 746 1Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon 28R 29 for Chronic Hepatitis C 746 2Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon 28R 29 for Chronic Hepatitis C 746 3Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon 28R 29 for Chronic Hepatitis C 746 4Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon 28R 29 for Chronic Hepatitis C 746 5Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon 28R 29 for Chronic Hepatitis C 746 6Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon 28R 29 for Chronic Hepatitis C 746 7Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon 28R 29 for Chronic Hepatitis C 746 8Kids Who Skimp on Sleep Tend to Be Fatter 5489 1Kids Who Skimp on Sleep Tend to Be Fatter 5489 2Kids Who Skimp on Sleep Tend to Be Fatter 5489 3Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 5484 1Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 5484 2Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 5484 3Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 5484 4Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 5484 5Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 5484 6Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 5484 7Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 5484 8Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 5484 9Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 5484 10Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 5484 11Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 5484 12Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 5484 13Allos Therapeutics Reports Third Quarter 2007 Financial Results 5479 1Allos Therapeutics Reports Third Quarter 2007 Financial Results 5479 2Allos Therapeutics Reports Third Quarter 2007 Financial Results 5479 3Allos Therapeutics Reports Third Quarter 2007 Financial Results 5479 4Allos Therapeutics Reports Third Quarter 2007 Financial Results 5479 5Allos Therapeutics Reports Third Quarter 2007 Financial Results 5479 6Allos Therapeutics Reports Third Quarter 2007 Financial Results 5479 7...ging muscles don,t heal like young ones. But it tu...the Feb. 17 issue of Nature shows that it,s old bl... by Thomas Rando, MD, PhD, associate professor of ...d University School of Medicine, built on previous...o repair themselves but fail to do so. Rando and h...
...uth and throat, surgery is a frequent course of tr...sfunction and external scarring. Researchers from ...s Department of Otorhinolaryngology/Head and Neck ...rehensive and largest to date ?that demonstrate th...stem to perform Trans-Oral Robotic Surgery (TORS) ...
...ime that human eggs may develop directly from cult...d from adult human ovaries. Oocytes derived from t...ture eggs suitable for fertilization and developme... in the Open Access journal Reproductive Biology a...or use in in vitro fertilization and stem cell res...
... 2 and 4 has detected the largest "gene deserts" k...ce that human chromosome 2 arose from the fusion o...rted by the National Human Genome Research Institu...lth (NIH), reported today. , In a study published ...i-institution team, led by Washington University S...
Other Biology News:Young Blood Revives Aging Muscles, Stanford Researchers Find 2Young Blood Revives Aging Muscles, Stanford Researchers Find 3Penn Researchers Use Robotic Surgery 2Penn Researchers Use Robotic Surgery 3Human Eggs Can Develop From Ovarian Surface Cells In Vitro 2Scientists analyze chromosomes 2 and 4 2Scientists analyze chromosomes 2 and 4 3(Date:7/2/2008)...e of two distinct drugs on separat...ly 2 /- Boston Scientific,C...U.S. Food and Drug,Administration (FDA) has approv...t System for the treatment of coronary artery dise...TM) V Everolimus-Eluting Coronary,Stent System man...
(Date:7/2/2008)...growing line of injectable ...wswire/ -- Bioniche Pharma, a leading,developer an...unced today,the acquisition of Baxter Healthcare C... ENLON(R) (edrophonium chloride injection, USP) 10...chloride, USP and atropine sulfate, USP) Injec...
(Date:7/2/2008)... Technology Receive Funding, From Allied Minds to ...of Aliquots, BOSTO... investment,corporation specializing in early stag...,s Office of Technology Development, and Northeast... Instruments, LLC, a new,spin-out focused on the e...
(Date:7/2/2008)...ent R2 levels as a possible pre...RNewswire-FirstCall/ - Lorus Therapeutics Inc. (TS... a biopharmaceutical company,specializing in the r... and,technologies for the management of cancer, to...ity (OSU) clinical team of a paper entitled "Phase...
Breaking Biology Technology:Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System 2Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System 3Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System 4Bioniche Pharma Acquires Baxter's ENLON(R) and ENLON-PLUS(R) 2Investment Firm Allied Minds to Commercialize New Frozen Aliquotter Technology with Two Local Major Universities. 2Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 2Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 3Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 4Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 5...a PARIS Kit--Optimized for Recovery of siRNA and m...Small RNA, mRNA, and Protein , Ambion,s ...ogical advances from both the <A , ...p?1560">mir <A , href="http://... miRNA Isolation Kit , optimized for small RNA re...
... Amplifies as little as 100 ng RNA , ... Percent Present Calls and low , ...cludes ArrayScript , M-MLV RT e... cDNA , The best in vitro ...lable , Better Reverse Tran...
...om the Recognized Leader in High Yield Transcripti...he most , frequently cited larg... reason. It enables the consistent tran...ull-length RNA (Figure 1). Ambion offers a complet...ly optimized to generate the following , ...
... RNA amplification using the Van Gelde...has been used extensively for target , ...xperiments. , Amplification of ... limited samples (needle biopsies, LC...ecessary when the availability of sample is not li...
Other Biology Technology:Isolate Total RNA and Protein From the Same Sample 2Isolate Total RNA and Protein From the Same Sample 3Isolate Total RNA and Protein From the Same Sample 4Isolate Total RNA and Protein From the Same Sample 5MessageAmp II: Use Less RNA for Array Analysis 2MessageAmp II: Use Less RNA for Array Analysis 3MessageAmp II: Use Less RNA for Array Analysis 4MessageAmp II: Use Less RNA for Array Analysis 5MessageAmp II: Use Less RNA for Array Analysis 6MessageAmp II: Use Less RNA for Array Analysis 7High Yield Transcription for Every Application 2High Yield Transcription for Every Application 3High Yield Transcription for Every Application 4High Yield Transcription for Every Application 5Is RNA Amplification Necessary for Microarrays? 2Is RNA Amplification Necessary for Microarrays? 3Is RNA Amplification Necessary for Microarrays? 4Is RNA Amplification Necessary for Microarrays? 5Is RNA Amplification Necessary for Microarrays? 6Normal donkey serum collected from healthy normal donkeys.
acridine orange 10-nonyl bromide (nonyl acridine orange)
MOUSE ANTI RAT RT1Bu / MOUSE Ia:BIOTIN Immunogen: Rat thymocyte membrane glycoproteins
Prepared in 0.85% saline.
Biology Products: